tirzepatide articles Effects of on Body Composition, Metabolic Parameters, and Sleep Outcomes: A Real-World One-Year Prospective Study Eli Lilly's Popular Weight Loss

A glimpse of various pathogenetic mechanisms of diabetic nephropathy

7583% achieved 15% 26% of participants on 12 mg achieved 30% weight reduction Cardiometabolic Parameters Improvements in blood pressure, HbA1c, fasting glucose, insulin, LDL-cholesterol 72% of patients with prediabetes achieved normoglycemia Safety Most common adverse events: gastrointestinal (nausea, diarrhea, constipation) , dose-dependent, predominantly mild to moderate Heart rate: slight increase up to week 24, then decrease No severe hypoglycemia, medullary carcinoma, or C-cell hyperplasia Conclusions Retatrutide induced significant, dose-dependent weight reduction of up to 24.2% over 48 weeks

Clinical trials have found they help reduce major cardiovascular events in people with obesity, reduce sleep apnea and also lower the risk of kidney disease

Biesenbach, G., Raml, A., Schmekal, B